Armen Shanafelt Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Armen Shanafelt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Armen Shanafelt. Armen Shanafelt is Director in Protagonist Therapeutics, Inc ($PTGX) and Director in AILERON THERAPEUTICS INC ($ALRN) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and Director in Surface Oncology, Inc. ($SURF).
Latest Insider Trading Transactions of Armen Shanafelt
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGLE, ALRN, PTGX, SURF
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.80 | 40,000 | 272,000 | 40,000 | |
| Jun 12 2020 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| Oct 03 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 1.17 | 16,531 | 19,341 | 16,531 | |
| Jun 07 2019 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.33 | 12,400 | 78,492 | 12,400 | |
| Jun 07 2019 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.33 | 12,400 | 78,492 | 12,400 | |
| Jun 06 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
| Jun 06 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 | |
| Jun 25 2018 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | A | 6.02 | 10,000 | 60,200 | 10,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 08 2018 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 10.28 | 18,400 | 189,152 | 18,400 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Buy | P | 15.00 | 266,000 | 3,990,000 | 3,447,817 | 3.2 M to 3.4 M (+8.36 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Buy | C | 0.00 | 3,181,817 | 0 | 3,181,817 | 0 to 3.2 M |
| Dec 05 2017 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 4.73 | 30,000 | 141,900 | 30,000 | |
| Jul 27 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | A | 13.00 | 20,000 | 260,000 | 20,000 | |
| Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 1,443,972 | 0 | 0 | |
| Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 1,654,411 | 0 | 0 | |
| Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 1,907,373 | 0 | 0 | |
| Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 3,390,885 | 0 | 0 | |
| Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Buy | P | 15.00 | 250,000 | 3,750,000 | 1,094,987 | 845 K to 1.1 M (+29.59 %) |
| Jul 07 2017 | ALRN | AILERON THERAPEUTI ... | Shanafelt Armen | Director | Buy | C | 0.00 | 844,987 | 0 | 844,987 | 0 to 845 K |
| May 26 2017 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
| Sep 15 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 9,841,333 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 9,142,857 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,099,482 | 1.5 M to 2.1 M (+38.47 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | C | 0.00 | 678,712 | 0 | 1,516,149 | 837.4 K to 1.5 M (+81.05 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | C | 0.00 | 630,541 | 0 | 837,437 | 206.9 K to 837.4 K (+304.76 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | C | 0.00 | 206,896 | 0 | 206,896 | 0 to 206.9 K |
| May 19 2016 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 7.28 | 24,000 | 174,720 | 24,000 |
Page: 1